title: Supracricoid laryngectomies: long-term oncological and functional results.
abstract: CONCLUSIONS
  Our results confirm that supracricoid laryngectomies (SL) are reliable techniques for glottosupraglottic tumors, even for selected T3 and T4 cases, if the indications are correct. These surgical techniques allow a good quality of life with the preservation of the larynx.
  
  
  OBJECTIVE
  SL with cricohyoidoepiglottopexy (CHEP) and cricohyoidopexy (CHP) have been popular over the last 20 years for the treatment of the glottic and/or supraglottic squamous cell carcinoma due to demonstrated good oncological and functional results. We report our experience with these techniques, with special focus on long-term oncological and functional results.
  
  
  METHODS
  We retrospectively reviewed 206 patients who had undergone SL with CHEP or CHP technique between 1987 and 1998 for glottosupraglottic squamous cell carcinoma in our department. The long-term results for 206 patients with T1-T4 laryngeal carcinomas treated with SL are reported: 90.8% CHEP and 9.2% CHP. The mean follow-up was 62 months.
  
  
  RESULTS
  Oncological results: the 5-year actuarial disease-free survival was 85%; the 5-year determinate actuarial survival was 88.3%. Functional results: organ preservation rate was 97%. Phonation was assessed according to the GRBAS scale.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Ospedale Maggiore, Bologna, Italy.
authors.forename: Pasquale
authors.initials: P
authors.lastname: Laudadio
authors.forename: Livio
authors.initials: L
authors.lastname: Presutti
authors.forename: Danilo
authors.initials: D
authors.lastname: Dall'olio
authors.forename: Elio
authors.initials: E
authors.lastname: Cunsolo
authors.forename: Roberto
authors.initials: R
authors.lastname: Consalici
authors.forename: Luca
authors.initials: L
authors.lastname: Amorosa
authors.forename: Alessandra
authors.initials: A
authors.lastname: Cancellieri
authors.forename: Corso
authors.initials: C
authors.lastname: Bocciolini
mesh_terms: D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D003413:Cricoid Cartilage / Q000601:surgery*; D018572:Disease-Free Survival; D004825:Epiglottis / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D006928:Hyoid Bone / Q000473:pathology / Q000601:surgery*; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D007825:Laryngectomy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010699:Phonation / Q000502:physiology*; D011183:Postoperative Complications / Q000175:diagnosis* / Q000401:mortality / Q000503:physiopathology; D012189:Retrospective Studies; D016019:Survival Analysis